Home » NOVARTIS PHARMA OBTAINS ADDITIONAL APPROVAL FOR ITS PROPRIETARY IMMUNOSUPPRESSANT NEORAL
NOVARTIS PHARMA OBTAINS ADDITIONAL APPROVAL FOR ITS PROPRIETARY IMMUNOSUPPRESSANT NEORAL
Novartis Pharma has obtained additional approval for Neoral (cyclosporine), its proprietary immunosuppressant, from the Ministry of Health, Labor and Welfare.
JCN Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May